Exclusive

Publication

Byline

Ultrahuman and Abu Dhabi Public Health Centre partner to build Biological Age model

Singapore, Oct. 13 -- The Abu Dhabi Public Health Centre (ADPHC) has signed a strategic Memorandum of Understanding (MoU) with Ultrahuman Healthcare SP LLC, a global health technology company and TIME... Read More


Korea's GCCL signs MoU with LabConnect to expand global clinical trial collaboration

Singapore, Oct. 13 -- GCCL, a South Korea-based leading global clinical trial central laboratory, has signed a Memorandum of Understanding (MoU) with US-based LabConnect, to expand global clinical tri... Read More


Australia's Firebrick Pharma secures $732k in strategic investments

Singapore, Oct. 12 -- Australia-based Firebrick Pharma has secured firm commitments from strategic investors for approximately $732k, through the placement of approximately 20.9 million fully paid ord... Read More


Philanthropy Asia Alliance backs Southeast Asia Heat Health Hub's next phase

Singapore, Oct. 12 -- The Philanthropy Asia Alliance (PAA) has announced its support for the next stage of the Global Heat Health Information Network (GHHIN) Southeast Asia Hub at the Global Heat Foru... Read More


Foresee Pharma announces China NMPA approval of CAMCEVI(R) 42 mg for treatment of advanced prostate cancer

Singapore, Oct. 12 -- Taiwan-based Foresee Pharmaceuticals has been notified by its licensing partner, Changchun GeneScience Pharmaceutical (GenSci), that China's National Medical Products Administrat... Read More


Korea's Lunit collaborates with US-based Discovery Life Sciences to expand AI-powered tissue analysis for biopharma research

Singapore, Oct. 12 -- South Korea-based Lunit, a leading provider of AI for cancer diagnostics and precision oncology, has announced a strategic collaboration with Discovery Life Sciences, a global le... Read More


Everest Medicines announces NMPA acceptance of LEROCHOL BLA for hypercholesterolemia

Singapore, Oct. 12 -- Everest Medicines announced on June 26, 2026, that China's National Medical Products Administration (NMPA) accepted the Biologics License Application (BLA) for LEROCHOL (lerodalc... Read More


Danaher accelerates Life Sciences research with new AI-powered autonomous lab

Singapore, Oct. 9 -- US-based Danaher Corporation has announced plans to launch its first AI-powered autonomous lab, designed to help researchers develop custom antibodies and other molecular tools fa... Read More


Japan's Shimadzu initiates validation of mass spec solution for core labs in Australia

Singapore, Oct. 9 -- Japan-based Shimadzu Corporation has started the development and validation of a mass spectrometry (MS) solution for core laboratories at St. Vincent's Hospital in Melbourne, Vict... Read More


India-UK collaboration to enhance skill set in healthcare

Singapore, Oct. 9 -- Marengo Asia Hospitals and BAPIO Training Academy, in association with the Ministry of Ayush, Government of India, have announced initiatives in clinical skill upgradation of AYUS... Read More